Sotera Health Q1 net loss $13M includes $31M EO settlement; Adj EBITDA up 8.8%

Sotera Health Co

2025-Q1 EPS reported -$0.05 revenue$254,523,000

Net revenues $255M, up 2.6% YoY (4.4% constant currency). Sterigenics segment $170M.
Net loss $13M ($0.05 diluted loss) vs net income $6M ($0.02) in Q1 2024; includes $31M EO settlement charge.
Adjusted EBITDA $122M, up 8.8% (11.2% constant currency). Adjusted EPS $0.14 vs $0.13.
Company reaffirms FY2025 constant-currency outlook: 4-6% net revenue growth, 4.5-6.5% Adj EBITDA growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.